Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yesim Dargaud

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 30, 2023
A focus on dominant negative variants in a series of 170 heterozygous FXI-deficient patientsPhilippe de Mazancourt, Florence Quélin, Claire Flaujac, et al.
Thrombosis and Haemostasis|August 11, 2025
Whole PROC Gene Sequencing to Explain Genetically Unresolved Protein C DeficienciesLaetitia Mauge, Carla Rial, Philippe De Mazancourt, et al.
European Journal of Haematology|February 7, 2023
Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation DisordersMarc Trossaert, Valerie Chamouard, Christine Biron-Andreani, et al.
British Journal of Haematology|April 25, 2009
A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective studyYesim Dargaud, Lucia Rugeri, Marie Christine Vergnes, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2024
Whole F8 gene sequencing identified pathogenic structural variants in the remaining unsolved patients with severe hemophilia AYohann Jourdy, Nicolas Chatron, Mathilde Frétigny, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2025
Accurate evaluation of factor VIII activity of efanesoctocog alfa in the presence of emicizumabChristophe Nougier, Steven W Pipe, Ingrid Pabinger, et al.
Plos One|November 1, 2023
Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literatureJoseph R Shaw, Tyler James, Jonathan Douxfils, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2024
Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or BBrigitte Tardy-Poncet, Aurélie Montmartin, Hervé Chambost, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Treatment of severe bleeds with eptacog beta in hemophilia A or B with inhibitors: a post hoc analysis of the PERSEPT 1 and 2 trialsGuy Young, Johnny Mahlangu, Lisa N Boggio, et al.
British Journal of Haematology|September 25, 2024
Impaired microvascular function in patients with sickle cell anemia and leg ulcers improved with healingJudith Catella, Etienne Turpin, Philippe Connes, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 30, 2023
A focus on dominant negative variants in a series of 170 heterozygous FXI-deficient patientsPhilippe de Mazancourt, Florence Quélin, Claire Flaujac, et al.
Thrombosis and Haemostasis|August 11, 2025
Whole PROC Gene Sequencing to Explain Genetically Unresolved Protein C DeficienciesLaetitia Mauge, Carla Rial, Philippe De Mazancourt, et al.
European Journal of Haematology|February 7, 2023
Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation DisordersMarc Trossaert, Valerie Chamouard, Christine Biron-Andreani, et al.
British Journal of Haematology|April 25, 2009
A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective studyYesim Dargaud, Lucia Rugeri, Marie Christine Vergnes, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2024
Whole F8 gene sequencing identified pathogenic structural variants in the remaining unsolved patients with severe hemophilia AYohann Jourdy, Nicolas Chatron, Mathilde Frétigny, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2025
Accurate evaluation of factor VIII activity of efanesoctocog alfa in the presence of emicizumabChristophe Nougier, Steven W Pipe, Ingrid Pabinger, et al.
Plos One|November 1, 2023
Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literatureJoseph R Shaw, Tyler James, Jonathan Douxfils, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2024
Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or BBrigitte Tardy-Poncet, Aurélie Montmartin, Hervé Chambost, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Treatment of severe bleeds with eptacog beta in hemophilia A or B with inhibitors: a post hoc analysis of the PERSEPT 1 and 2 trialsGuy Young, Johnny Mahlangu, Lisa N Boggio, et al.
British Journal of Haematology|September 25, 2024
Impaired microvascular function in patients with sickle cell anemia and leg ulcers improved with healingJudith Catella, Etienne Turpin, Philippe Connes, et al.
Pageof 13